In the News - FDA

What's New with FDA?

Judge Jesus Bernal ruled in federal court in California’s Central District against the FDA’s argument that a group of stem cell clinics …

While aging affects most living organisms, the hydrozoan Turritopsis dohrniiis the only species able to rejuvenate repeatedly after sexual reproduction, becoming biologically …

The FDA granted fast track designation to ALLO-316, an investigational chimeric antigen receptor T-cell therapy, for the treatment of adults with advanced …

Collection and analysis of real-world data (RWD) continue to gain traction in the biomedical community, accompanied by a growing understanding of RWD’s …

As medicines development continues towards a globalized approach, both the pharmaceutical industry and regulatory agencies increasingly seek opportunities to proactively engage early …

FDA Regenerative Medicine Webinar

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a public webinar on …